home / stock / xgn / xgn news

XGN News and Press, Exagen Inc. From 03/25/20

Stock Information
Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NYSE
Website: exagen.com
Menu
XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...
XGN - Exagen Inc. (XGN) CEO Ron Rocca on Q4 2019 Results - Earnings Call Transcript

Start Time: 16:30 End Time: 17:07 Exagen Inc. (XGN) Q4 2019 Earnings Conference Call March 25, 2020, 16:30 PM ET Company Participants Ron Rocca - President and CEO Kamal Adawi - CFO Mark Hazeltine - SVP of Finance & Corporate Development Conference Call Participants ...
XGN - Exagen EPS beats by $0.10, misses on revenue

Exagen (NASDAQ: XGN ): Q4 GAAP EPS of -$0.27 beats by $0.10 . More news on: Exagen Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

XGN - Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic interventi...

XGN - Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer

SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the appointment of Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer (CMO), ...
XGN - Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease

SAN DIEGO, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic interventio...

XGN - Exagen to Announce Fourth Quarter and Year-End 2019 Financial Results on March 25, 2020

SAN DIEGO, March 11, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic inter...

XGN - Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their Patients

SAN DIEGO, CA, March 09, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic interventio...
XGN - Exagen to Present at Cowen and Company 40th Annual Healthcare Conference

SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic interventio...

XGN - Interpace Biosciences Announces Addition to Board of Directors and Changes in Leadership

Ron Rocca, CEO of Exagen, appointed to Board James Early, CFO announces retirement; Fred Knechtel, formerly CFO of GENEWIZ, appointed as CFO Jeff Salzman, formerly of CareDX, appointed VP of Managed Care & Payer Relations PARSIPPANY, NJ, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Int...

XGN - Exagen Announces Addition to Russell 3000® and 2000® Indexes

SAN DIEGO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic interventio...
Previous 10 Next 10